It was reported that combination therapy with DHA and Apo2L/TRAIL promoted the induction of apoptosis in BxPC-3 and PANC-1 pancreatic cancer cells compared to monotherapy. The gene discussed is TNFSF10; the disease is familial pancreatic carcinoma.